VKTX logo

Viking Therapeutics (VKTX) Total Debt

Annual Total Debt

$1.26 M
-$304.00 K-19.44%

31 December 2023

VKTX Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Debt

$1.24 M
+$135.00 K+12.27%

30 September 2024

VKTX Quarterly Total Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

VKTX Total Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-19.4%-7.6%
3 y3 years+251.0%+973.9%
5 y5 years+100.0%+68.5%

VKTX Total Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-19.4%+4244.8%-25.2%+4158.6%
5 y5 years-19.4%-25.2%+4158.6%
alltimeall time-63.5%-66.8%

Viking Therapeutics Total Debt History

DateAnnualQuarterly
Sept 2024
-
$1.24 M(+12.3%)
June 2024
-
$1.10 M(-6.9%)
Mar 2024
-
$1.18 M(-6.3%)
Dec 2023
$1.26 M(-19.4%)
$1.26 M(-5.8%)
Sept 2023
-
$1.34 M(-5.4%)
June 2023
-
$1.41 M(-5.1%)
Mar 2023
-
$1.49 M(-4.7%)
Dec 2022
$1.56 M(+5293.1%)
$1.56 M(-4.4%)
Sept 2022
-
$1.64 M(-1.0%)
June 2022
-
$1.65 M(+0.7%)
Mar 2022
-
$1.64 M(+5555.2%)
Dec 2021
$29.00 K(-91.9%)
$29.00 K(-74.8%)
Sept 2021
-
$115.00 K(-41.9%)
June 2021
-
$198.00 K(-29.0%)
Mar 2021
-
$279.00 K(-22.3%)
Dec 2020
$359.00 K(-45.8%)
$359.00 K(-18.0%)
Sept 2020
-
$438.00 K(-14.8%)
June 2020
-
$514.00 K(-12.6%)
Mar 2020
-
$588.00 K(-11.2%)
Dec 2019
$662.00 K(>+9900.0%)
$662.00 K(-9.7%)
Sept 2019
-
$733.00 K(-8.5%)
June 2019
-
$801.00 K(-7.8%)
Mar 2019
-
$869.00 K(>+9900.0%)
DateAnnualQuarterly
Dec 2018
$0.00(-100.0%)
$0.00(0.0%)
Sept 2018
-
$0.00(0.0%)
June 2018
-
$0.00(-100.0%)
Mar 2018
-
$3.72 M(+7.8%)
Dec 2017
$3.45 M(+5.5%)
$3.45 M(+8.5%)
Sept 2017
-
$3.18 M(+4.3%)
June 2017
-
$3.05 M(-17.8%)
Mar 2017
-
$3.71 M(+13.6%)
Dec 2016
$3.27 M(+52.0%)
$3.27 M(+15.7%)
Sept 2016
-
$2.83 M(+18.6%)
June 2016
-
$2.38 M(-24.1%)
Mar 2016
-
$3.14 M(+45.9%)
Dec 2015
$2.15 M(+37.2%)
$2.15 M(+12.6%)
Sept 2015
-
$1.91 M(+14.4%)
June 2015
-
$1.67 M(-4.0%)
Mar 2015
-
$1.74 M(+11.0%)
Dec 2014
$1.57 M(+462.6%)
$1.57 M(>+9900.0%)
Sept 2014
-
$0.00(-100.0%)
June 2014
-
$611.80 K(+114.6%)
Mar 2014
-
$285.10 K(>+9900.0%)
Dec 2013
$278.80 K(+551.4%)
-
June 2013
-
$0.00(0.0%)
Mar 2013
-
$0.00(0.0%)
Dec 2012
$42.80 K
$0.00

FAQ

  • What is Viking Therapeutics annual total debt?
  • What is the all time high annual total debt for Viking Therapeutics?
  • What is Viking Therapeutics annual total debt year-on-year change?
  • What is Viking Therapeutics quarterly total debt?
  • What is the all time high quarterly total debt for Viking Therapeutics?
  • What is Viking Therapeutics quarterly total debt year-on-year change?

What is Viking Therapeutics annual total debt?

The current annual total debt of VKTX is $1.26 M

What is the all time high annual total debt for Viking Therapeutics?

Viking Therapeutics all-time high annual total debt is $3.45 M

What is Viking Therapeutics annual total debt year-on-year change?

Over the past year, VKTX annual total debt has changed by -$304.00 K (-19.44%)

What is Viking Therapeutics quarterly total debt?

The current quarterly total debt of VKTX is $1.24 M

What is the all time high quarterly total debt for Viking Therapeutics?

Viking Therapeutics all-time high quarterly total debt is $3.72 M

What is Viking Therapeutics quarterly total debt year-on-year change?

Over the past year, VKTX quarterly total debt has changed by -$102.00 K (-7.63%)